dupilumab copd phase 3

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
dupilumab copd phase 3	0.73	0.8	3690	27	22
dupilumab	0.41	0.6	5713	37	9
copd	1.21	0.4	2457	83	4
phase	0.47	0.9	7800	97	5
3	0.78	0.1	455	46	1

Keyword	CPC	PCC	Volume	Score
dupilumab copd phase 3	1.21	0.9	3468	32
dupilumab copd clinical trials	0.6	0.3	6593	47
dupilumab for copd with type 2 inflammation	0.58	1	8355	24
dupilumab eoe phase 3	1.86	0.7	1920	39
dupilumab asthma phase 2b	0.42	0.4	4907	39
dupilumab prurigo nodularis phase 3	0.99	0.9	9425	29
clinical trials for copd 2023	0.39	0.4	9651	53
dupilumab atopic dermatitis phase 3	1.26	0.1	3339	54
dupilumab eosinophilic esophagitis phase 3	0.34	0.8	9538	49
d3 &k2 cure for copd	0.17	0.5	6820	66
dupilumab mode of action	1.57	0.9	2069	10
dupilumab for severe asthma	0.63	1	8324	89
fiche info patient dupilumab	1.63	0.4	6749	77
dupilumab patient information leaflet	1.59	0.2	2023	45
copd clinical practice guidelines 2023	1.42	0.4	2588	21
dupilumab t1/2	0.67	0.6	3643	90
new treatment for copd 2023	1.41	0.4	339	50
dupilumab fda approval asthma	0.34	0.3	8583	72
copd treatment algorithm 2023	0.85	0.9	5619	15